Evaluation of bisbenzamidines as inhibitors for matriptase-2.
Bioorg Med Chem Lett
; 26(15): 3741-5, 2016 08 01.
Article
em En
| MEDLINE
| ID: mdl-27287367
The serine protease matriptase-2 has attracted much attention as a potential target for the treatment of iron overload diseases. In this study, a series of 27 symmetric, achiral bisbenzamidines was evaluated for inhibitory activity against human matriptase-2, against the closely related enzyme human matriptase, as well as against human thrombin, bovine factor Xa and human trypsin. The conformationally restricted piperazine derivative 19 and the oxamide-derived bisbenzamidine 1 were identified as the most potent inhibitors of this series for matriptase-2 and matriptase, respectively.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Benzamidinas
/
Inibidores de Serina Proteinase
/
Proteínas de Membrana
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article